These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9508425)

  • 21. Long-term secondary prophylaxis of Pneumocystis carinii pneumonia by inhaled pentamidine in AIDS.
    Fraisse P; Partisani M; Lang JM
    J Infect Dis; 1990 Oct; 162(4):1001. PubMed ID: 2401788
    [No Abstract]   [Full Text] [Related]  

  • 22. Susceptibility of Pneumocystis carinii to a Pichia anomala killer toxin.
    Séguy N; Aliouat EM; Dei-Cas E; Polonelli L; Camus D; Cailliez JC
    J Eukaryot Microbiol; 1994; 41(5):109S. PubMed ID: 7804202
    [No Abstract]   [Full Text] [Related]  

  • 23. Detection by immunofluorescent anti-idiotypic antibodies of yeast killer toxin cell wall receptors of Candida albicans.
    Polonelli L; Fanti F; Conti S; Campani L; Gerloni M; Castagnola M; Morace G; Chezzi C
    J Immunol Methods; 1990 Sep; 132(2):205-9. PubMed ID: 2170534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of Pneumocystis carinii pneumonia by multiple lobe, site-directed bronchoalveolar lavage with immunofluorescent monoclonal antibody staining in human immunodeficiency virus-infected patients receiving aerosolized pentamidine chemoprophylaxis.
    Levine SJ; Kennedy D; Shelhamer JH; Kovacs A; Feuerstein IM; Gill VJ; Stock F; Solomon D; Boylen CT; Masur H
    Am Rev Respir Dis; 1992 Oct; 146(4):838-43. PubMed ID: 1416407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies.
    Selvakumar D; Miyamoto M; Furuichi Y; Komiyama T
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3090-7. PubMed ID: 16940106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungals.
    Manfredi M; McCullough MJ; Conti S; Polonelli L; Vescovi P; Al-Karaawi ZM; Porter SR
    Oral Microbiol Immunol; 2005 Aug; 20(4):226-32. PubMed ID: 15943767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interfaces of the yeast killer phenomenon.
    Polonelli L; Conti S; Gerloni M; Magliani W; Chezzi C; Morace G
    Crit Rev Microbiol; 1991; 18(1):47-87. PubMed ID: 1854433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention of pneumocystosis with pentamidine aerosols].
    Fraisse P; Partisani M; Lang JM; Vandevenne A
    Presse Med; 1990 Nov; 19(38):1762-6. PubMed ID: 2147502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure of intravenous pentamidine prophylaxis for Pneumocystis carinii pneumonia.
    Weintrub PS; Wara DW; Duliege AM
    J Pediatr; 1993 Jan; 122(1):163-4. PubMed ID: 8419606
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro activity of monoclonal and recombinant yeast killer toxin-like antibodies against antibiotic-resistant gram-positive cocci.
    Conti S; Magliani W; Arseni S; Dieci E; Frazzi R; Salati A; Varaldo PE; Polonelli L
    Mol Med; 2000 Jul; 6(7):613-9. PubMed ID: 10997342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis.
    Polonelli L; Magliani W; Conti S; Bracci L; Lozzi L; Neri P; Adriani D; De Bernardis F; Cassone A
    Infect Immun; 2003 Nov; 71(11):6205-12. PubMed ID: 14573638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disseminated pneumocystosis without pulmonary involvement during prophylactic aerosolized pentamidine therapy in a patient with the acquired immunodeficiency syndrome.
    DeRoux SJ; Adsay NV; Ioachim HL
    Arch Pathol Lab Med; 1991 Nov; 115(11):1137-40. PubMed ID: 1747032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human natural yeast killer toxin-like candidacidal antibodies.
    Polonelli L; De Bernadis F; Conti S; Boccanera M; Magliani W; Gerloni M; Cantelli C; Cassone A
    J Immunol; 1996 Mar; 156(5):1880-5. PubMed ID: 8596040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of intravenous pentamidine for the prophylaxis of Pneumocystis pneumonia in pediatric patients.
    Kruizinga MD; Bresters D; Smiers FJ; Lankester AC; Bredius RGM
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28074607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic efficacies of GW471552 and GW471558, two new azasordarin derivatives, against pneumocystosis in two immunosuppressed-rat models.
    Jimenez E; Martínez A; Aliouat el M; Caballero J; Dei-Cas E; Gargallo-Viola D
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2648-50. PubMed ID: 12121948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of a monoclonal antibody using lymphocytes from Pneumocystis infected mice.
    Soulez B; Palluault F; Dei-Cas E; Aliouat EM; Camus D
    J Protozool; 1991; 38(6):189S-190S. PubMed ID: 1818162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pneumocystis hepatitis and choroiditis despite successful aerosolized pentamidine pulmonary prophylaxis.
    Hagopian WA; Huseby JS
    Chest; 1989 Oct; 96(4):949-51. PubMed ID: 2791697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of prophylaxis on the outcome of HIV-associated Pneumocystis carinii pneumonia.
    Ewig S
    Chest; 1996 Feb; 109(2):586-7. PubMed ID: 8620753
    [No Abstract]   [Full Text] [Related]  

  • 39. Randomized study of sulfamethoxazole-trimethoprim versus aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS.
    Nielsen TL; Jensen BN; Nelsing S; Mathiesen LR; Skinhøj P; Nielsen JO
    Scand J Infect Dis; 1995; 27(3):217-20. PubMed ID: 8539544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition by yeast killer toxin-like antibodies of oral Streptococci adhesion to tooth surfaces in an ex vivo model.
    Conti S; Magliani W; Arseni S; Frazzi R; Salati A; Ravanetti L; Polonelli L
    Mol Med; 2002 Jun; 8(6):313-7. PubMed ID: 12428062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.